Cell Therapy Technologies Market - Size, Industry Trends, Competitive Landscape, and Opportunities and Forecast 2022 - 2030
The Global Cell Therapy Technologies Market Size is evaluated at USD 2,986 Million in 2021 and is anticipated to reach USD 9,834 Million by 2030 with a CAGR of 14.3% from 2022 to 2030.
Cell therapy includes replacing diseased or damaged cells with new, healthy ones, altering the function of the patient's cells by the production of factors or direct interaction, and utilizing immune cells to remove disease-causing or malfunctioning cells.
Our researchers, who are at the forefront of regenerative medicine, now have a realistic goal: using cell therapy to prevent and reverse disease, repair organ damage, and ultimately treat many life-threatening conditions. Cell therapy research is thriving because of significant improvements in the understanding of disease biology and significant advancements in gene editing, protein engineering, and cell culture technologies.
Cell Therapy Technologies Market
Cell Therapy Technologies Market Size in 2021
US$ 2,986 Million
Cell Therapy Technologies Market Forecast By 2030
US$ 9,834 Million
Cell Therapy Technologies Market CAGR During 2022 – 2030
Cell Therapy Technologies Market Analysis Period
2018 - 2030
Cell Therapy Technologies Market Base Year
Cell Therapy Technologies Market Forecast Data
2022 - 2030
By Product Type, By Cell Type, By Cell Processing, By End-User, By Region
Cell Therapy Technologies Market Regional Scope
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled
Beckman Coulter, GE Healthcare, Lonza Group AG, Merck KGaA, Miltenyi Biotec, STEMCELL Technologies Inc., Thermo Fisher Scientific, and Terumo BCT Inc.
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
Cell Therapy Technologies Market Dynamics
As the research progresses, various cell types will be researched for potential applications and created into therapeutics as innovative cell therapies. The most popular kind of cell therapy for treating a range of hematologic and blood cancers is hematopoietic stem cell transplantation, often known as a bone marrow transplant. Cell treatments may be used to treat conditions such as cancer, autoimmune illness, urine issues, infectious disease, repair spinal cord injuries, and treat patients with neurological diseases. They may also be used to treat cancer, autoimmune disease, urinary difficulties, and infectious disease.
The demand for advanced cell therapy instruments is rising due to their affordability and sustainability, government and private organizations are investing more money in cell-based research therapy for lifestyle diseases like diabetes, and lower prices for stem cell therapies are causing an increased tendency to purchase. These factors are all contributing to the growth of the market for cell therapy technologies.
During the projected period, the market for cell treatment technologies will increase as a result of major players concentrating on expanding their manufacturing capacity. Sartorius launched its manufacturing facility in Yauco, Puerto Rico, on June 26, 2019. The site cost investment of up to USD 100 million. Given that the company has been increasing its presence in the U.S. over the past few years, the new site's goal is to serve the needs of the American market.
Cell Therapy Technologies Market Insights
The three categories of the global cell therapy technologies market are product type, cell type, cell processing, end-user, and region. Product type segment can be further divided into consumables, equipment, and systems & software. On the basis of Cell Type, the segmentation includes stem cells, t-cells, and other cells. Cell preservation, distribution, and handling and process monitoring and quality control are the bifurcations of cell processing segment. Furthermore, end-user sub-segment is split into biopharmaceutical & biotechnology companies and CROs and research institutes and cell banks.
Global Cell Therapy Technologies Market Geographical Competition
The North American, European, Latin American, Asian Pacific, and Middle Eastern & African regions make up the five geographical segments of the worldwide cell therapy technologies market. During the projection period, North America is expected to be a significant market. This is because research and development activities have significantly increased. The region's market is expected to grow as a result of new technologies and equipment that have been developed as a result of developments in the health care industry. Over the forecast period, Asia Pacific is expected to experience the fastest growth. The market in the area is anticipated to grow as a result. Significant prospects exist in the market for cell treatment technologies in developing nations including India, South Korea, Brazil, and China.
Global Cell Therapy Technologies Industry Segment Analysis
Cell Therapy Technologies Market By Product Type
- Systems & Software
Cell Therapy Technologies Market By Cell Type
Cell Therapy Technologies Market By Cell Processing
Cell Preservation, Distribution, and Handling
Process Monitoring and Quality Control
Cell Therapy Technologies Market By End-User
Research Institutes and Cell Banks
Biopharmaceutical & Biotechnology Companies and CROs
This section of the study honors the market's top vendors Beckman Coulter, GE Healthcare, Lonza Group AG, Merck KGaA, Miltenyi Biotec, STEMCELL Technologies Inc., Thermo Fisher Scientific, and Terumo BCT Inc.
Cell Therapy Technologies Market Regions
Cell Therapy Technologies Market Leading Companies
- Rest of Europe
- Rest of Latin America
- South Korea
- Rest of Asia-Pacific
The Middle East & Africa (MEA)
- Gulf Cooperation Council (GCC)
- South Africa
- Rest of the Middle East & Africa